Inflammation potentiates cochlear uptake of ototoxins and drug-induced hearing loss

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Serious bacterial infections are often treated with aminoglycosides, especially when the cause of systemic infection is unknown. Severe infections trigger specific systemic inflammatory response pathways. Aminoglycosides are primarily trafficked across the cochlear blood-labyrinth barrier into the stria vascularis, prior to clearance into endolymph and entry into hair cells with subsequent cytotoxicity and loss of auditory function: cochleotoxicity. Systemic inflammation potentiates cochlear uptake of aminoglycosides and increases the risk of hearing loss in both preclinical models and human studies. Here, we review the data that establishes the above narrative, and articulate the need for translational studies to promote ototoxicity monitoring in neonatal intensive care units and cystic fibrosis clinics.

Original languageEnglish (US)
Title of host publicationInflammatory Mechanisms in Mediating Hearing Loss
PublisherSpringer International Publishing
Pages133-147
Number of pages15
ISBN (Electronic)9783319925073
ISBN (Print)9783319925066
DOIs
StatePublished - Jul 18 2018

Fingerprint

Cochlea
Aminoglycosides
Hearing Loss
Inflammation
Pharmaceutical Preparations
Endolymph
Stria Vascularis
Neonatal Intensive Care Units
Inner Ear
Infection
Bacterial Infections
Cystic Fibrosis

Keywords

  • Aminoglycosides
  • Drug trafficking
  • Infection
  • Ototoxicity
  • Stria vascularis

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Steyger, P. (2018). Inflammation potentiates cochlear uptake of ototoxins and drug-induced hearing loss. In Inflammatory Mechanisms in Mediating Hearing Loss (pp. 133-147). Springer International Publishing. https://doi.org/10.1007/978-3-319-92507-3_7

Inflammation potentiates cochlear uptake of ototoxins and drug-induced hearing loss. / Steyger, Peter.

Inflammatory Mechanisms in Mediating Hearing Loss. Springer International Publishing, 2018. p. 133-147.

Research output: Chapter in Book/Report/Conference proceedingChapter

Steyger, P 2018, Inflammation potentiates cochlear uptake of ototoxins and drug-induced hearing loss. in Inflammatory Mechanisms in Mediating Hearing Loss. Springer International Publishing, pp. 133-147. https://doi.org/10.1007/978-3-319-92507-3_7
Steyger P. Inflammation potentiates cochlear uptake of ototoxins and drug-induced hearing loss. In Inflammatory Mechanisms in Mediating Hearing Loss. Springer International Publishing. 2018. p. 133-147 https://doi.org/10.1007/978-3-319-92507-3_7
Steyger, Peter. / Inflammation potentiates cochlear uptake of ototoxins and drug-induced hearing loss. Inflammatory Mechanisms in Mediating Hearing Loss. Springer International Publishing, 2018. pp. 133-147
@inbook{7d8ffc0ba85f4bd1a9ad97a37ecb4934,
title = "Inflammation potentiates cochlear uptake of ototoxins and drug-induced hearing loss",
abstract = "Serious bacterial infections are often treated with aminoglycosides, especially when the cause of systemic infection is unknown. Severe infections trigger specific systemic inflammatory response pathways. Aminoglycosides are primarily trafficked across the cochlear blood-labyrinth barrier into the stria vascularis, prior to clearance into endolymph and entry into hair cells with subsequent cytotoxicity and loss of auditory function: cochleotoxicity. Systemic inflammation potentiates cochlear uptake of aminoglycosides and increases the risk of hearing loss in both preclinical models and human studies. Here, we review the data that establishes the above narrative, and articulate the need for translational studies to promote ototoxicity monitoring in neonatal intensive care units and cystic fibrosis clinics.",
keywords = "Aminoglycosides, Drug trafficking, Infection, Ototoxicity, Stria vascularis",
author = "Peter Steyger",
year = "2018",
month = "7",
day = "18",
doi = "10.1007/978-3-319-92507-3_7",
language = "English (US)",
isbn = "9783319925066",
pages = "133--147",
booktitle = "Inflammatory Mechanisms in Mediating Hearing Loss",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Inflammation potentiates cochlear uptake of ototoxins and drug-induced hearing loss

AU - Steyger, Peter

PY - 2018/7/18

Y1 - 2018/7/18

N2 - Serious bacterial infections are often treated with aminoglycosides, especially when the cause of systemic infection is unknown. Severe infections trigger specific systemic inflammatory response pathways. Aminoglycosides are primarily trafficked across the cochlear blood-labyrinth barrier into the stria vascularis, prior to clearance into endolymph and entry into hair cells with subsequent cytotoxicity and loss of auditory function: cochleotoxicity. Systemic inflammation potentiates cochlear uptake of aminoglycosides and increases the risk of hearing loss in both preclinical models and human studies. Here, we review the data that establishes the above narrative, and articulate the need for translational studies to promote ototoxicity monitoring in neonatal intensive care units and cystic fibrosis clinics.

AB - Serious bacterial infections are often treated with aminoglycosides, especially when the cause of systemic infection is unknown. Severe infections trigger specific systemic inflammatory response pathways. Aminoglycosides are primarily trafficked across the cochlear blood-labyrinth barrier into the stria vascularis, prior to clearance into endolymph and entry into hair cells with subsequent cytotoxicity and loss of auditory function: cochleotoxicity. Systemic inflammation potentiates cochlear uptake of aminoglycosides and increases the risk of hearing loss in both preclinical models and human studies. Here, we review the data that establishes the above narrative, and articulate the need for translational studies to promote ototoxicity monitoring in neonatal intensive care units and cystic fibrosis clinics.

KW - Aminoglycosides

KW - Drug trafficking

KW - Infection

KW - Ototoxicity

KW - Stria vascularis

UR - http://www.scopus.com/inward/record.url?scp=85063364241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063364241&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-92507-3_7

DO - 10.1007/978-3-319-92507-3_7

M3 - Chapter

SN - 9783319925066

SP - 133

EP - 147

BT - Inflammatory Mechanisms in Mediating Hearing Loss

PB - Springer International Publishing

ER -